Matthias Gimpel

Dr. Matthias Gimpel

Chair of Bioprocess Engineering, Institute of Biotechnology, Technische Universität Berlin, Ackerstraße 76, 13355 Berlin, Germany
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2019 in Journal of Natural Products
Verified
Journal Article
Closed access
FKFelix Kaspar
Felix Kaspar
Peter NeubauerPeter Neubauer
Peter Neubauer
Matthias GimpelMatthias Gimpel
Matthias Gimpel

11 May 2010 in Molecular Microbiology
Verified
Journal Article
Open access
PDF file
Matthias GimpelMatthias Gimpel
Matthias Gimpel
NHNadja Heidrich
Nadja Heidrich
UMUlrike Mäder
Ulrike Mäder
HKHans Krügel
Hans Krügel
SBSabine Brantl
Sabine Brantl
Summary: Small non‐coding RNAs (sRNAs) have been found to regulate gene expression in all three kingdoms of life. So far, relatively little is known about sRNAs from Gram‐positive bacteria. SR1 is a regulatory sRNA from the Bacillus subtilis chromosome that inhibits by base‐pairing translation initiation of ahrC mRNA encoding a transcriptional activator of the arginine catabolic operons. Here we present a novel target of SR1, the glycolytic gapA operon. Both microarray and Northern blot analyses show that the amount of gapA operon mRNA is significantly higher in the presence of SR1 when cells were grown in complex medium until stationary phase. Translational lacZ fusions and toeprinting analyses demonstrate that SR1 does not promote translation of gapA mRNA. By contrast, the half‐life of gapA operon mRNA is strongly reduced in the sr1 knockout strain. SR1 does not act as a base‐pairing sRNA on gapA operon mRNA. Instead, we demonstrate that the 39 aa peptide encoded by SR1, SR1P, is responsible for the effect of SR1 on the gapA operon. We show that SR1P binds GapA, thereby stabilizing the gapA operon mRNA by a hitherto unknown mechanism. SR1 is the first dual‐function sRNA found in B. subtilis.

14 November 2016 in Molecular Microbiology
Verified
Journal Article
Closed access
PDF file
Matthias GimpelMatthias Gimpel
Matthias Gimpel
SBSabine Brantl
Sabine Brantl

2 October 2012 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
Matthias GimpelMatthias Gimpel
Matthias Gimpel
HPHeike Preis
Heike Preis
EBEmanuel Barth
Emanuel Barth
LGLydia Gramzow
Lydia Gramzow
SBSabine Brantl
Sabine Brantl
SR1 is a dual-function sRNA that acts as a base-pairing regulatory RNA on the ahrC mRNA and as a peptide-encoding mRNA on the gapA operon. The SR1-encoded peptide SR1P binds GapA thereby stabilizing gapA mRNA. Under glycolytic conditions, SR1 transcription is repressed by CcpN and CcpA. A computer-based search identified 23 SR1 homologues in Bacillus, Geobacillus, Anoxybacillus and Brevibacillus species. All homologues share a high structural identity with Bacillus subtilis SR1, and the encoded SR1P peptides are highly similar. In the Bacillus cereus group, the sr1p region is present in triplicate or duplicate resulting in longer SR1 species. In all cases, sr1 expression is under control of CcpN, and transcriptional lacZ fusions of nine examined SR1 homologues were sensitive to glucose. Two homologues showed an additional glucose-independent repression by CcpN and an unknown factor. A total of 10 out of 11 tested SR1P homologues complemented a B. subtilis Δsr1 strain in their ability to stabilize gapA mRNA, but only five of them bound GapA tightly. In vitro binding assays with six SR1/ahrC pairs suggest that—despite divergent primary sequences—the base-pairing function is also preserved. In summary, SR1 is an sRNA with two functions that have been conserved over ≈1 billion years.

1 May 2019 in RNA Biology
Verified
Journal Article
Open access
PMPeter Müller
Peter Müller
Matthias GimpelMatthias Gimpel
Matthias Gimpel
TWTheresa Wildenhain
Theresa Wildenhain
SBSabine Brantl
Sabine Brantl
CsrA is a widely conserved, abundant small RNA binding protein that has been found in E. coli and other Gram-negative bacteria where it is involved in the regulation of carbon metabolism, biofilm formation and virulence. CsrA binds to single-stranded GGA motifs around the SD sequence of target mRNAs where it inhibits or activates translation or influences RNA processing. Small RNAs like CsrB or CsrC containing 13–22 GGA motifs can sequester CsrA, thereby abrogating the effect of CsrA on its target mRNAs. In B. subtilis, CsrA has so far only been found to regulate one target, hag mRNA and to be sequestered by a protein (FliW) and not by an sRNA. Here, we employ a combination of in vitro and in vivo methods to investigate the effect of CsrA on the small regulatory RNA SR1 from B. subtilis, its primary target ahrC mRNA and its downstream targets, the rocABC and rocDEF operons. We demonstrate that CsrA can promote the base-pairing interactions between SR1 and ahrC mRNA, a function that has so far only been found for Hfq or ProQ. Abbreviations: aa, amino acid; bp, basepair; nt, nucleotide; PAA, polyacrylamide; SD, Shine Dalgarno.

Verified
Journal Article
Open access
PDF file
QFQin Fan
Qin Fan
Peter NeubauerPeter Neubauer
Peter Neubauer
OLOliver Lenz
Oliver Lenz
Matthias GimpelMatthias Gimpel
Matthias Gimpel
Hydrogenases are complex metalloenzymes, showing tremendous potential as H2-converting redox catalysts for application in light-driven H2 production, enzymatic fuel cells and H2-driven cofactor regeneration. They catalyze the reversible oxidation of hydrogen into protons and electrons. The apo-enzymes are not active unless they are modified by a complicated post-translational maturation process that is responsible for the assembly and incorporation of the complex metal center. The catalytic center is usually easily inactivated by oxidation, and the separation and purification of the active protein is challenging. The understanding of the catalytic mechanisms progresses slowly, since the purification of the enzymes from their native hosts is often difficult, and in some case impossible. Over the past decades, only a limited number of studies report the homologous or heterologous production of high yields of hydrogenase. In this review, we emphasize recent discoveries that have greatly improved our understanding of microbial hydrogenases. We compare various heterologous hydrogenase production systems as well as in vitro hydrogenase maturation systems and discuss their perspectives for enhanced biohydrogen production. Additionally, activities of hydrogenases isolated from either recombinant organisms or in vivo/in vitro maturation approaches were systematically compared, and future perspectives for this research area are discussed.